Quartz 5

待人工审核

Showing 108 of 108 entries
页面类型页面状态审核状态独立来源数更新日期
2026-07-14 乳腺癌ADC组会讲解笔记sourceneeds-reviewunreviewed12026-07-17
2026-07-14 乳腺癌ADC综述——从精准递送到肿瘤微环境重编程sourceneeds-reviewunreviewed12026-07-17
2026-07-15 cmLumiOpto线粒体靶向基因治疗联合PARP抑制剂治疗TNBCsourceneeds-reviewunreviewed12026-07-15
2026-07-15 ECM硬度通过TYK2机械转导调控乳腺癌转移sourceneeds-reviewunreviewed12026-07-15
2026-07-15 FGFR3-PARP1磷酸化介导PARP抑制剂耐药sourceneeds-reviewunreviewed12026-07-15
2026-07-15 HER3上调经ATR-CHK1-FoxO1轴降低DS-8201敏感性sourceneeds-reviewunreviewed12026-07-15
2026-07-15 HR阳性HER2阳性乳腺癌MUKDEN分型sourceneeds-reviewunreviewed12026-07-15
2026-07-15 HR阳性HER2阴性转移性乳腺癌CDK4-6抑制剂耐药综述sourceneeds-reviewunreviewed12026-07-15
2026-07-15 mTORC1自噬缺陷形成PI3K抑制剂耐药的代谢脆弱性sourceneeds-reviewunreviewed12026-07-15
2026-07-15 ncRNA介导HER2阳性肿瘤曲妥珠单抗耐药机制sourceneeds-reviewunreviewed12026-07-17
2026-07-15 P001-P018中期全库审计报告maintenanceactiveunreviewed—2026-07-15
2026-07-15 P004maintenanceneeds-review——2026-07-15
2026-07-15 P005组会讲解笔记——单细胞RNA测序预测CDK4-6抑制剂进展sourceneeds-reviewunreviewed12026-07-15
2026-07-15 P006组会讲解笔记——CDK4-6抑制剂耐药综述sourceneeds-reviewunreviewed12026-07-15
2026-07-15 P008组会讲解笔记——乳腺癌PARP抑制剂治疗sourceneeds-reviewunreviewed12026-07-15
2026-07-15 P009组会讲解笔记——FGFR3-PARP1磷酸化与PARP抑制剂耐药sourceneeds-reviewunreviewed12026-07-15
2026-07-15 P019maintenanceneeds-review——2026-07-17
2026-07-15 P022maintenanceneeds-review——2026-07-17
2026-07-15 P024maintenanceneeds-review——2026-07-15
2026-07-15 PARP抑制剂诱导T细胞DNA损伤与抗肿瘤效应sourceneeds-reviewunreviewed12026-07-15
2026-07-15 PI3K-AKT-mTOR抑制剂用于HR阳性晚期乳腺癌sourceneeds-reviewunreviewed12026-07-15
2026-07-15 RUNX1-PDGF-BB轴介导CDK4-6抑制剂耐药sourceneeds-reviewunreviewed12026-07-15
2026-07-15 SHR-A1811新辅助疗效的空间决定因素sourceneeds-reviewunreviewed12026-07-18
2026-07-15 USP10-GSK3β-PTEN轴介导PI3K抑制剂耐药sourceneeds-reviewunreviewed12026-07-15
2026-07-15 乳腺癌PARP抑制剂治疗综述sourceneeds-reviewunreviewed12026-07-17
2026-07-15 乳腺癌原发灶与转移淋巴结多组学图谱sourceneeds-reviewunreviewed12026-07-17
2026-07-15 乳腺癌研究文献点评与阅读导引sourceneeds-reviewunreviewed02026-07-15
2026-07-15 单细胞RNA测序预测CDK4-6抑制剂晚期进展sourceneeds-reviewunreviewed12026-07-18
2026-07-15 单细胞空间转录组追踪乳腺癌侵袭演化sourceneeds-reviewunreviewed12026-07-18
2026-07-15 多组学预测乳腺癌新辅助治疗反应sourceneeds-reviewunreviewed12026-07-15
2026-07-15 戈沙妥珠单抗与他拉唑帕利序贯治疗转移性三阴性乳腺癌sourceneeds-reviewunreviewed12026-07-15
2026-07-15 教学资料 TS001maintenanceneeds-review——2026-07-15
2026-07-15 早期乳腺癌循环肿瘤DNA监测综述sourceneeds-reviewunreviewed12026-07-15
2026-07-15 癌症中的细胞死亡sourceneeds-reviewunreviewed12026-07-15
2026-07-15 艾立布林用于转移性三阴性乳腺癌的回顾性研究sourceneeds-reviewunreviewed12026-07-15
2026-07-15 顺铂联合Veliparib治疗BRCA-like转移性TNBCsourceneeds-reviewunreviewed12026-07-15
2026-07-17 2026 ASCO转移性乳腺癌的多样治疗方案与共同难题sourceneeds-reviewunreviewed12026-07-18
2026-07-17 ELAVL3-MYCN正反馈回路驱动神经内分泌前列腺癌sourceneeds-reviewunreviewed12026-07-17
2026-07-17 P025maintenanceneeds-review——2026-07-17
2026-07-17 P026maintenanceneeds-review——2026-07-17
2026-07-17 P027maintenanceneeds-review——2026-07-17
2026-07-17 SUBITO试验强化化疗对比含铂化疗序贯Olaparibsourceneeds-reviewunreviewed12026-07-17
2026-07-17 ZNF689缺失使TNBC对PARP与PD-L1联合抑制敏感sourceneeds-reviewunreviewed12026-07-17
2026-07-17 乳腺癌免疫治疗需要重画免疫地图sourceneeds-reviewunreviewed12026-07-18
2026-07-17 乳腺癌患者T-DXd耐药后怎么办——MSK队列研究公众号解读sourceneeds-reviewunreviewed12026-07-17
2026-07-17 选择性省略浸润性乳腺癌手术的非随机临床试验sourceneeds-reviewunreviewed12026-07-17
2026-07-18 体内模块化抗体-ADC连接逆转肿瘤耐药sourceneeds-reviewunreviewed12026-07-18
2026-07-18 细胞因子驱动乳腺癌转移的系统综述sourceneeds-reviewunreviewed12026-07-18
2026-07-18 肿瘤异质性的动态生态系统综述sourceneeds-reviewunreviewed12026-07-18
ADC序贯治疗conceptactiveunreviewed32026-07-15
ADC耐药机制conceptactiveunreviewed42026-07-18
Alpelisibentityactiveunreviewed22026-07-15
BRCA1-2entityactiveunreviewed52026-07-17
CDK4-6抑制剂entityactiveunreviewed42026-07-15
CDK4-6抑制剂耐药conceptactiveunreviewed42026-07-15
Dato-DXdentityactiveunreviewed22026-07-17
DNA损伤反应conceptactiveunreviewed72026-07-17
EGFRentityneeds-reviewunreviewed22026-07-18
gBRCA1-2与非gBRCA人群的PARP抑制剂证据comparisonactiveunreviewed22026-07-17
HER2低表达乳腺癌entityneeds-reviewunreviewed32026-07-18
HER2空间异质性conceptactiveunreviewed22026-07-18
HER2阳性肿瘤entityactiveunreviewed72026-07-17
HER3entityactiveunreviewed32026-07-15
HR阳性HER2阳性乳腺癌entityactiveunreviewed32026-07-15
HR阳性HER2阴性转移性乳腺癌entityactiveunreviewed32026-07-15
Olaparibentityactiveunreviewed62026-07-17
PARP1entityactiveunreviewed22026-07-15
PARP抑制剂entityactiveunreviewed82026-07-17
PARP抑制剂耐药conceptactiveunreviewed22026-07-15
PARP捕获conceptactiveunreviewed42026-07-15
PD-L1entityactiveunreviewed32026-07-17
PI3K-AKT-mTOR信号通路conceptactiveunreviewed52026-07-17
PI3K抑制剂entityactiveunreviewed42026-07-15
PI3K抑制剂耐药conceptactiveunreviewed22026-07-15
PI3K抑制剂耐药的PTEN反馈与自噬缺陷代谢脆弱性comparisonactiveunreviewed22026-07-15
PIK3CA突变乳腺癌entityactiveunreviewed32026-07-15
PTENentityactiveunreviewed22026-07-15
T-DM1与T-DXd的结构和耐药差异comparisonactiveunreviewed22026-07-15
T-DXdentityactiveunreviewed42026-07-18
TROP-2entityactiveunreviewed22026-07-15
Veliparibentityactiveunreviewed22026-07-15
三阴性乳腺癌entityactiveunreviewed112026-07-17
上皮-间质转化conceptactiveunreviewed52026-07-18
乳腺癌entityactiveunreviewed252026-07-17
免疫原性细胞死亡conceptactiveunreviewed22026-07-15
免疫逃逸conceptactiveunreviewed22026-07-17
单细胞RNA测序conceptactiveunreviewed22026-07-18
合成致死conceptactiveunreviewed22026-07-17
同源重组缺陷conceptactiveunreviewed62026-07-17
回答answeractiveunreviewed0{{date}}
实体entityactiveunreviewed2{{date}}
实验SOP草稿experimentaldraftunreviewed1{{date}}
对比comparisonactiveunreviewed2{{date}}
循环肿瘤DNA监测conceptactiveunreviewed32026-07-17
抗体偶联药物entityactiveunreviewed72026-07-18
故障排查experimentaldraftunreviewed0{{date}}
新辅助治疗反应预测conceptactiveunreviewed32026-07-15
曲妥珠单抗entityactiveunreviewed22026-07-17
来源-组会文献sourceactiveunreviewed1{{date}}
来源-通用资源sourceactiveunreviewed1{{date}}
概念conceptactiveunreviewed2{{date}}
病理完全缓解conceptactiveunreviewed32026-07-17
空间多组学conceptactiveunreviewed22026-07-15
肿瘤免疫微环境conceptactiveunreviewed122026-07-18
肿瘤异质性conceptactiveunreviewed42026-07-18
肿瘤浸润淋巴细胞entityactiveunreviewed32026-07-17
肿瘤相关巨噬细胞entityneeds-reviewunreviewed22026-07-18
问题questionactiveunreviewed0{{date}}

Graph View